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Abstract
Background and Aims-Diminished folate status is associated with enhanced colorectal carcinogenesis. This study investigated the potential chemopreventive role of dietary folate in the dimethylhydrazine colorectal cancer model. Subjects and Methods-Sprague-Dawley rats were fed diets containing either 0, 2 (daily dietary requirement), 8 or 40 mg folatelkg diet for 20 weeks. After five weeks of diet, rats were injected with dimethylhydrazine (44 mg/kg) weekly for 15 weeks. Fifteen weeks after the first injection of dimethylhydrazine, all rats were killed. Folate status was determined, and the entire colorectum from each rat was analysed for macroscopic and microscopic neoplasms. Results-Plasma and colonic folate concentrations correlated directly with dietary folate levels (p<0.005). The incidence of microscopic neoplasms was similar among the four groups. However, the incidence and the average number of macroscopic tumours per rat decreased progressively with increasing dietary folate levels up to 8 mg/kg diet (p<0.05). In the strongly procarcinogenic milieu used in this study, folate supplementation at 20 times the basal requirement was associated with rates ofmacroscopic tumour development that were Recently, considerable interest has been focused on folate because diminished status of the vitamin has been shown in epidemiological and animal studies to be associated with an increased risk of neoplastic transformation.78 Epidemiological studies conducted in people with ulcerative colitis,9 10 as well as in the general population," '7 indicate a 30-50% reduction in colorectal neoplasia among those with higher, rather than lower, folate status. The most convincing evidence that diminished dietary folate intake is associated with an increased risk of colorectal neoplasia has been recently published by Giovannucci et al. '7 This prospective study included over 25 000 cohorts and correct for the most of the well known dietary confounders associated with colorectal cancer. The study observed a 40% reduction in the risk of developing colorectal adenomas in subjects with the highest amount of dietary folate intake compared with those with the lowest intake. More recently, prospectively conducted clinical studies have shown that red blood cell'8 or colonic mucosal'9 folate concentrations are significantly lower in those harbouring adenomas compared with control subjects, thereby supporting epidemiological findings.
In support of the causal inferences suggested by epidemiological studies, previous work in the dimethylhydrazine The other section was rolled up into a 'Swiss roll', a means by which an intact longitudinal section of the entire length of the colorectum can be presented on a single microscope slide,32 fixed in 10% formalin, and processed for light microscopy. A single longitudinal section (5 jum) was cut from the midline of each Swiss roll, without regard to the presence of macroscopic lesions, and stained with haematoxylin and eosin. As midline sections were cut without regard to the presence of macroscopic or microscopic lesions, each 5 ,um section in this study constituted a random and representative longitudinal section from the entire length of the colon of each rat.32 This method has previously been used to quantitatively and qualitatively describe DMH induced lesions in the colorectum.20 32 Assessment of the microscopic lesions were thereby performed in a manner that was independent of the assessment of macroscopic lesions.
Two experienced pathologists read the slides independently and in a blinded fashion. Two separate readings were obtained to assess concordance, thereby establishing a measure of objectivity in the histopathological analysis. The entire length of each colon was carefully examined for megaloblastic changes and neoplastic foci. Each focus of neoplasia was recorded with respect to its location (proximal v distal) and was classified into low or high grade dysplasia (LGD and HGD, respectively) or invasive adenocarcinoma according to previously described criteria. 33 The DNA from colonic mucosal scrapings were extracted by a standard technique using a lysis buffer containing proteinase K followed by phenol, chloroform, and isoamyl alcohol organic extraction. 40 The resulting DNA was precipitated with 1 M NaCl and 100% ethanol and was treated with RNAse. The purified DNA was further dialysed against 10 mM TRIS-HCI, 1 mM EDTA, pH 8.0. The size of DNA estimated by agarose gel electrophoresis was >20 kb in all instances. No RNA contamination was detected on agarose gel electrophoresis. The final preparations had an A260/280 ratio >1 8. The purified DNA was stored at -70°C until the DNA methylation assay.
Genome wide methylation status at CpG from colonic mucosal DNA was determined by the in vitro methyl acceptance capacity of DNA using [3H-methyl] SAM as a methyl donor and a prokaryotic CpG DNA methyltransferase as previously described and validated.26'40 The manner in which this assay is performed produces a reciprocal relation between the endogenous DNA methylation status and the exogenous 3H-methyl incorporation. Briefly, two jig of DNA were incubated in 5 ,uCi of [3H-methyl] SAM (New England Nuclear Boston, MA; 3-10 Ci/mmol), four units of Sssl methylase (New England Biolabs, Beverly, MA), one volume Sssl buffer (50 mM NaCl, 10 mM TRIS-HCI, 10 mM EDTA, 1 mM dithiothreitol, pH 8.0) in a total volume of 50 ,lI methylation mixture for three hours at 37°C. Sssl was denatured by heating at 65°C for 20 minutes. The incubation mixtures were applied onto discs of Whatman DE-81 ion exchange filters (Fisher Scientific Springfield, NJ) using vacuum filtration apparatus, and the discs were then washed with 5% NaH2PO4 for 45 minutes. The discs were then dried at 95°C for 30 minutes and the resulting radioactivity of the DNA retained in the discs was measured by scintillation counting using a non-aqueous scintillation fluor. The amount of radiolabel bound to a filter from an incubation mixture lacking DNA was used as background and was subtracted from the values obtained with mixtures containing DNA. The background value was always < 1% of the uptake observed with DNA samples. All analyses were done in duplicate.
For histopathological analyses, the entire population of rats (n= 10) from each group were analysed. However, for other biochemical and molecular analyses, adequate amounts of plasma and colonic tissue were not available from one rat from the folate deplete group and hence this rat was excluded from these analyses.
For continuous response variables, differences among dietary groups were assessed by using single factor analysis of variance. When the overall F ratio achieved statistical significance, orthogonal polynomial contrasts, after a square root transformation of dietary folate, and Fisher's least significant differences were used to better understand the nature of the between group differences. For discrete response variables, differences among groups were assessed by using a Kruskal Body weight and average dailyfood consumption Growth curves were similar in the four groups of rats; at no time point did the mean weights differ significantly among these groups. No premature death occurred. This finding indicates that the folate deficiency in the rats that were fed 0 mg folate/kg diet was not severe, otherwise growth retardation or premature death would have occurred.29 The average daily food consumptions, which were determined on a pre-assigned day of each week were also similar among the four groups (data not shown).
Folate and SAM status As Figure 1 shows, the mean plasma and colonic mucosal folate concentrations were different among the four groups (p<0001, ANOVA) and correlated directly with the levels of dietary folate (p<0 001 and p=0003, respectively). However, colonic folate concentrations reached a plateau beyond four times the basal requirement of folate. This finding is probably related to the fact that folate Haemoglobin, packed cell value, and mean corpuscular volume were not significantly different among the four groups (data not shown).
Colonic mucosal concentrations of SAM as well as SAH, the second of which accumulates as a result of folate deficiency and which indicates a decreased ability to remethylate homocysteine, 23 were not significantly different among the four groups (data not shown). Furthermore, the ratio of SAM to SAH, considered by some as a better indicator of methylating capacity,45 was similar among the four groups (data not shown).
Microscopic lesion analysis
The two independent analyses of microscopic lesions by two pathologists were highly correlated: LGD, r=0-3, p=01; HGD, r=0.6, p<0-001; and invasive cancer, r=0 9, p<0Q001.
Furthermore, all analyses pertaining to microscopic data had identical outcomes regardless of which histopathological data set were used (data not shown Macroscopic tumour analysis Most of the macroscopic tumours (90%) were located in the distal colon. Non-specific submucosal fold thickening without vascular abnormalities were present in a similar proportion of rats in each group and most of these (91 %) were located in the proximal colon. Two rats had hepatic, and peritoneal and omental metastatic lesions, respectively: both were in the group receiving 0 mg folate/kg diet. As Figure 2 shows, the proportion of rats harbouring macroscopic tumours decreased progressively with increasing levels of dietary folate up to Similarly, Figure 3 shows that the average number of macroscopic tumours per rat decreased progressively with increasing levels of dietary folate up to 8 mg folate/kg diet (p=0.036, Kruskal-Wallis; p=0016 Jonkheere Terpstra test for trend) and that a nonsignificant trend towards greater numbers of macroscopic tumours per rat was evident in the group receiving 40 mg folate/kg diet compared with those receiving 8 mg folate/kg diet.
The size of the macroscopic tumours ranged from 2.0 mm to 6-7 mm. The average size of the macroscopic tumours were not significantly different among the four groups, although a trend similar to the incidence and the average number of macroscopic tumours per rat was observed In our previous study, 100% of the rats that were fed 0 mg folate/kg diet developed microscopic neoplasia 20 weeks after receiving DMH (20 mg/kg body weight) injections compared with 29% of the rats that were fed 8 mg folate/kg diet (p<0O.05).20 In contrast, the proportion of macroscopic tumours between the folate depleted and control groups was not significantly different (86% v 43%, p=O09).20
The earlier study, therefore, suggested that folate deficiency acts on an early phase of DMH induced colorectal carcinogenesis.20 In the present study, the dose of DMH (44 mg/kg body weight) was more than twice the dose used in the previous study, and was deliberately chosen to create a very strong procarcinogenic milieu to elucidate more effectively the effect of folate supplementation on the progression of microscopic neoplastic foci to macroscopic tumours. As the induction of colonic neoplasms by DMH is dose 21 22 dependent, not surprisingly, almost all rats had microscopic neoplastic foci, independent of the levels of dietary folate, at a time point that was five weeks earlier than that of the previous experiment. However, this study clearly demonstrates that folate supplementation renders protection against the evolution of microscopic neoplastic foci to macroscopic tumours in a dose responsive manner. Taken together, these data suggest that folate insufficiency or supplementation has modulatory effects on the development of colorectal neoplasms in rats injected with DMH and that the exact stages of tumorigenesis on which it has the most profound effect seems to be related to the DMH doses used. The schedule used in this study does not permit us to distinguish whether the modulatory effects of dietary folate are exerted on the initiation or promotional stages of carcinogenesis: future studies are warranted to consider this issue.
The degree of folate depletion observed in the rats fed 0 mg folate/kg diet was moderate as evidenced by the plasma and colonic mucosal folate concentrations as well as the absence of growth retardation and premature death. Though the folate depletion was only moderate, there was evidence of biochemically significant folate deficiency, as indicated by the modest rise in plasma homocysteine concentrations compared with those of the folate replete rats. This is consistent with other observations that indicate that this magnitude of folate depletion is known to be associated with functionally significant degree of cellular folate depletion within the colonic mucosa.T herefore, the finding that even a mild to moderate degree of folate depletion can potentiate the action of DMH on the development of macroscopic tumours in rats further substantiates the epidemiological and clinical studies that have suggested that a modest reduction in folate status is all that is necessary for enhancement of colorectal carcinogenesis when other risk factors are present.9-20 Moreover, the fact that those rats fed the daily requirement of folate had a higher incidence of macroscopic tumours compared with those supplemented with folate at four times the daily requirement is consistent with observations from some of the epidemiological studies where the risk of developing colorectal cancer or its precursor, adenoma, is decreased in subjects taking higher amounts of dietary folate than the recommended daily allowance. '7 Homocysteine is significantly increased in the folate depleted animals compared with the replete groups even though colonic mucosal SAM, SAH, and SAM/SAH ratio are not significantly changed in this group. Interestingly, colonic SAH is not increased in the folate depleted animals even though homocysteine accumulation favours a backwards reaction whereby SAH is created. These observations are consistent with an earlier study where SAM and SAH from the liver and colonic mucosa were compared in rats receiving 0 and 8 mg folate/kg diet.26 In that study, plasma homocysteine concentrations were threefold higher in the folate depleted rats compared with the folate replete animals, an effect that was present in association with a significant increase in hepatic SAH and significant decrease in hepatic SAM. However, in the earlier study,26 as is true in this one, no significant changes in colonic SAM and SAH were observed. This is probably related to the fact that the degree to which one carbon metabolism is affected by folate depletion is highly tissue dependent.36 Furthermore, it reflects the fact that homocysteine is distributed in the body in a highly compartmentalised and heterogeneous fashion47 and therefore an accumulation of homocysteine in the plasma does not necessarily imply its accumulation in the colonic mucosa.
We observed a highly significant positive correlation between the plasma concentration of folate and the concentration of folate in the colonic mucosa; this is consistent with earlier studies in rats that observed similarly strong correlations between serum folate levels and folate levels in the gastrointestinal tract. 48 Nevertheless, in a recent study in humans,49 no such correlation was observed between either plasma or red blood cell folate concentrations and concentrations in isolated colonocytes. In the instance of this second study, colonocytes were first isolated and allowed to equilibrate for several hours before the determination of folate content. In contrast, our method stabilises the folate content at the time of tissue isolation and is furthermore designed to determine the folate concentration of all the contents of colonic mucosa, including epithelial mucous and cells from the lamina propria, both of which are important constituents of the environment in which colonic epithelial cells exist. Therefore, the apparent discrepancy between our study and the abovementioned human study maybe ascribable to species differences or methodological differences: future studies should help clarify this issue.
The observations in this study indicate that the significant, and progressive, decline in colorectal neoplasia that is observed with increasing levels of dietary folate does not continue at levels of folate that exceed four times the daily requirement. The fact that there is no significant difference in the incidence of macroscopic neoplasia between the 8 and 40 mg/kg groups (see Figs 2 and 3 ) may merely reflect the fact that maximal mucosal content of folate is achieved on the 8 mg/kg diet (Fig 1) . Nevertheless, a nonsignificant trend towards increased macroscopic neoplasms in the 40 mg/kg group is evident in Figures 2 and 3 and may indicate a difference in the inhibition of carcinogenesis between the 8 and 40 mg/kg groups. A definitive explanation for this trend is not available from our observations, but it should be interpreted in light of the potent procarcinogenic milieu that was used in this study. Supplemental folate may have two distinct actions in this setting: at lower levels of supplementation it seems to possess an inhibitory effect on genesis of microscopic foci of neoplasia, as has been previously described,20 as well as the evolution ofmacroscopic neoplasms from microscopic ones. Independently, in a strongly procarcinogenic environment where the appearance of microscopic neoplasms is inevitable, exceptionally high supplemental levels may promote the growth of microscopic neoplasms: an 'acceleration phenomenon', which has previously been described in humans who have well established cancers and who are given exceptionally large doses of folate.50 Studies incorporating larger numbers of animals are necessary to fully determine whether the upward trend between 8 and 40 mg/kg reflects a true difference.
The mechanisms by which folate insufficiency increases the risk of, and folate supplementation conveys protection against, colorectal neoplasia remain unclear at present. Because of the intimate relation of folate to biological methylation reactions23 and the role of aberrant patterns of DNA methylation in carcinogenesis,224 several investigators have proposed that one such mechanism might be altered DNA methylation as a result of change in folate status.7 8 20 However, the genomic DNA methylation data from our study indicate that moderate folate depletion, and supplementation up to 20 times the daily requirement, in conjunction with DMH treatment, were not associated with changes in genomic DNA methylation. These data suggest that the modulatory effect of dietary folate on colonic neoplasia in the DMH model is not mediated by changes in genomic DNA methylation. This is consistent with recent observations that indicate that a moderate degree of folate depletion, equivalent to that of the rats fed 0 mg folate/kg diet in the present study, does not induce genome-wide or c-myc protooncogene specific DNA hypomethylation in the colon. 26 There are several possible explanations why alterations in dietary folate were not observed to alter genomic DNA methylation in the colon. Firstly, the colonic mucosal SAM concentration and the ratio of SAM to SAH, two critical determinants in biological methylation23 45 were similar among the four groups of rats. This may be due to the fact that modulation of SAM and SAH in some tissues such as the colonic mucosa might be particularly resistant to the effect of folate deficiency or supplementation, as indicated by a previous study. 26 The manner in which the colons were processed in this study precluded histological analysis of the macroscopic lesions. Nevertheless, there is a compelling body of evidence in rodent models of colon cancer, utilising either DMH or its metabolites, which indicates that macroscopic lesions invariably contain neoplastic foci.32 6370 A deliberate choice was made at the outset of this study to include only those macroscopic lesions with features of neoplasia as described in the literature63~70: non-specific submucosal thickening without vascular abnormalities were specifically excluded from the macroscopic tumour analysis. Most of the macroscopic neoplastic lesions were located in the distal colon, consistent with other studies,6>70
whereas almost all submucosal thickenings were found in the proximal colon near the caecum.
In summary, these data corroborate earlier observations that raised folate status may play an inhibitory part in DMH induced colorectal carcinogenesis. These data indicate that the progression from microscopic to macroscopic neoplasms is inhibited by dietary folate. These data also indicate that this modulatory effect extends over a wide range of folate status. Nevertheless, at levels of supplementation exceeding four times the basal requirement, no protective effect was apparent. The implications for chemoprevention in humans are provocative, but unclear at the present time. 
